H
Hemda Schmilovitz-Weiss
Researcher at Rabin Medical Center
Publications - 55
Citations - 891
Hemda Schmilovitz-Weiss is an academic researcher from Rabin Medical Center. The author has contributed to research in topics: Population & Internal medicine. The author has an hindex of 15, co-authored 48 publications receiving 782 citations. Previous affiliations of Hemda Schmilovitz-Weiss include Peking University & Tel Aviv University.
Papers
More filters
Journal ArticleDOI
Lamivudine treatment for acute severe hepatitis B: a pilot study.
Hemda Schmilovitz-Weiss,Ziv Ben-Ari,E. Sikuler,Eli Zuckerman,Wisam Sbeit,Zvi Ackerman,Rifaat Safadi,Yoav Lurie,Guy Rosner,Ran Tur-Kaspa,Ron Reshef +10 more
TL;DR: The use of lamivudine in the treatment of immunocompetent patients with acute hepatitis B is limited and its use in clinical practice is still under investigation.
Journal ArticleDOI
Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
Manuela G. Neuman,Jean-Pierre Benhamou,Patrick Marcellin,Dominique Valla,Izabella M. Malkiewicz,Gad G. Katz,Cristhian Trepo,Marc Bourlière,Ross G. Cameron,Lawrence Cohen,Mary Morgan,Hemda Schmilovitz-Weiss,Ziv Ben-Ari +12 more
TL;DR: Interleukin-8 increased significantly at higher histological activity indices and continued to increase in patients with cirrhosis, and Transforming growth factor-beta levels increased significantly with the severity of fibrosis, but decreased in cirrhotics.
Journal ArticleDOI
Does a colonoscopy after acute diverticulitis affect its management?: a single center experience.
Hemda Schmilovitz-Weiss,Evgen Yalunin,Mona Boaz,Vered Sehayek-Shabbat,Izhak Levin,Alexandra Chervinski,Eli Atar,Yaron Niv,Haim Shirin +8 more
TL;DR: The results suggest that colonoscopy does not affect the management of patients with acute diverticulitis nor alter the outcome, and the current practice of a routine Colonoscopy after acute diverticsulitis needs to be reevaluated.
Journal ArticleDOI
Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
Cuiying Chen,Hemda Schmilovitz-Weiss,Xue-En Liu,Orit Pappo,Marisa Halpern,Jaqueline Sulkes,Marius Braun,Maya Cohen,Nir Barak,Ran Tur-Kaspa,Valerie Vanhooren,Hans Van Vlierberghe,Claude Libert,Roland Contreras,Ziv Ben-Ari +14 more
TL;DR: The serum N-glycan profile is a promising noninvasive method for detecting NASH or NASH-related fibrosis in NAFLD patients, which could be a valuable supplement to other markers currently used in diagnosis of NASH.
Journal ArticleDOI
Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
Talia Weinstein,Avry Chagnac,Mona Boaz,Yaacov Ori,Michal Herman,Dina Zevin,Hemda Schmilovitz-Weiss,Uzi Gafter +7 more
TL;DR: The results of this study show that the third-generation HBV vaccine Bio-Hep-B® is highly immunogenic in the population of ESRD patients who did not respond in the past to a second-generation vaccine.